GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » PT Millennium Pharmacon International Tbk (ISX:SDPC) » Definitions » Intrinsic Value: Projected FCF

PT Millennium Pharmacon International Tbk (ISX:SDPC) Intrinsic Value: Projected FCF : Rp-312.94 (As of Jun. 18, 2025)


View and export this data going back to 1990. Start your Free Trial

What is PT Millennium Pharmacon International Tbk Intrinsic Value: Projected FCF?

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company. The details of how we calculate the intrinsic value of stocks are described in detail here.

As of today (2025-06-18), PT Millennium Pharmacon International Tbk's Intrinsic Value: Projected FCF is Rp-312.94. The stock price of PT Millennium Pharmacon International Tbk is Rp128.00. Therefore, PT Millennium Pharmacon International Tbk's Price-to-Intrinsic-Value-Projected-FCF of today is 0.0.

The historical rank and industry rank for PT Millennium Pharmacon International Tbk's Intrinsic Value: Projected FCF or its related term are showing as below:

ISX:SDPC's Price-to-Projected-FCF is not ranked *
in the Medical Distribution industry.
Industry Median: 0.89
* Ranked among companies with meaningful Price-to-Projected-FCF only.

PT Millennium Pharmacon International Tbk Intrinsic Value: Projected FCF Historical Data

The historical data trend for PT Millennium Pharmacon International Tbk's Intrinsic Value: Projected FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PT Millennium Pharmacon International Tbk Intrinsic Value: Projected FCF Chart

PT Millennium Pharmacon International Tbk Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Intrinsic Value: Projected FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only -138.00 -48.12 -65.02 -346.40 -453.48

PT Millennium Pharmacon International Tbk Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Intrinsic Value: Projected FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -540.98 -709.14 -552.50 -453.48 -312.94

Competitive Comparison of PT Millennium Pharmacon International Tbk's Intrinsic Value: Projected FCF

For the Medical Distribution subindustry, PT Millennium Pharmacon International Tbk's Price-to-Projected-FCF, along with its competitors' market caps and Price-to-Projected-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PT Millennium Pharmacon International Tbk's Price-to-Projected-FCF Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, PT Millennium Pharmacon International Tbk's Price-to-Projected-FCF distribution charts can be found below:

* The bar in red indicates where PT Millennium Pharmacon International Tbk's Price-to-Projected-FCF falls into.


;
;

PT Millennium Pharmacon International Tbk Intrinsic Value: Projected FCF Calculation

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company.

The details of how we calculate the intrinsic value of stocks are described in detail here.

This method smooths out the free cash flow over the past 6-7 years, multiplies the results by a growth multiple, and adds a portion of Total Stockholders Equity.

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + 0.8 * Total Stockholders Equity (most recent) ) / Shares Outstanding (Diluted Average)

In the case of negative Total Stockholders Equity, the following formula is used (see Explanation section below for the reason):

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + Total Stockholders Equity (most recent) / 0.8 ) / Shares Outstanding (Diluted Average)


Add all the Free Cash Flow together and divide 6 will get PT Millennium Pharmacon International Tbk's Free Cash Flow(6 year avg) = Rp-47,848.99.

PT Millennium Pharmacon International Tbk's Intrinsic Value: Projected FCF for today is calculated as

Intrinsic Value: Projected FCF=(Growth Multiple*Free Cash Flow (6 year avg)+Total Stockholders Equity (Mar25)*0.8)/Shares Outstanding (Diluted Average)
=(13.228282734574*-47848.99296+292849.253*0.8)/1274.000
=-312.94

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PT Millennium Pharmacon International Tbk  (ISX:SDPC) Intrinsic Value: Projected FCF Explanation

The growth multiple is capped between 8.35 and 17.74.

Total Stockholders Equity weighting is more art than science and it should always be revisited in more detail when researching a company. Weightings from 0% to 100% to more than 100% are possible. 80% was chosen as a happy median after taking the above ideas into consideration.

PT Millennium Pharmacon International Tbk's Price-to-Intrinsic-Value-Projected-FCF for today is calculated as

Price-to-Intrinsic-Value-Projected-FCF=Share Price/Intrinsic Value: Projected FCF
=128.00/-312.93611070605
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PT Millennium Pharmacon International Tbk Intrinsic Value: Projected FCF Related Terms

Thank you for viewing the detailed overview of PT Millennium Pharmacon International Tbk's Intrinsic Value: Projected FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


PT Millennium Pharmacon International Tbk Business Description

Traded in Other Exchanges
N/A
Address
Jl. Sultan Iskandar Muda No 18/Jl. Bungur No. 1, Crown Bungur Arteri Lantai 2-4, Kel. Kebayoran Lama Selatan, Kec. Kebayoran Lama, Selatan, Jakarta, IDN, 12240
PT Millennium Pharmacon International Tbk is engaged in distributing medicines, food supplements, and medical disposables. The operating segments of the group are Prescription medicine, Non-prescription medicine, and Medical devices, of which the majority of the revenue is derived from the Prescription Medicine segment.. The company's geographical segments are Java, Sumatera, Kalimantan, Sulawesi, and Bali.

PT Millennium Pharmacon International Tbk Headlines

No Headlines